J. Chacartegui

发表

Follow up analysis by exosomal miRNAs in EGFR mutated non-small cell lung cancer (NSCLC) patients during osimertinib (AZD9291) treatment: A potential prognostic biomarker tool.

P. Pauwels, M. Peeters, C. Rolfo, 2016 .

Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice

P. Pauwels, C. Rolfo, M. Castiglia, 2016, Oncotarget.